

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in field cancerization and... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-690/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-690" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas.">
            <meta name="og:description" content="Read the latest article version by Sean R. Christensen, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13910">
            <meta name="article-id" content="12837">
            <meta name="dc.title" content="Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas">
            <meta name="dc.description" content="Cutaneous squamous cell carcinoma (SCC) is among the most common cancers in humans, and many patients with SCC will develop multiple tumors within their lifetime. The field cancerization concept, originally proposed over 60 years ago, hypothesized that multiple primary cancers may arise simultaneously and coexist with subclinical precursor lesions within a defined field. Genetic sequencing of SCC and precursor lesions has identified what may be the earliest clonal proliferations in SCC development and confirmed that field cancerization in the skin is mediated by ultraviolet radiation. For patients with multiple SCCs and severe actinic damage, treatment of precursor lesions within a cancerized field can decrease the risk of subsequent cancer development. Sunblock is an effective intervention for field cancerization, even in patients with established disease. There is now direct evidence that field therapy with topical 5-fluorouracil is effective in reducing the incidence of subsequent SCC, and there is indirect evidence suggesting that topical imiquimod, topical ingenol mebutate, and photodynamic therapy are similarly effective. There is limited direct evidence to show that systemic acitretin or nicotinamide can decrease incident SCC in patients with field cancerization. In this review, an approach to the management of patients with multiple SCCs and field cancerization is presented along with the rationale to support field-directed therapy.">
            <meta name="dc.subject" content="cutaneous squamous cell carcinoma, field cancerization, lesion-directed therapy ">
            <meta name="dc.creator" content="Christensen, Sean R.">
            <meta name="dc.date" content="2018/06/01">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12837.1">
            <meta name="dc.source" content="F1000Research 2018 7:690">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="cutaneous squamous cell carcinoma">
            <meta name="prism.keyword" content="field cancerization">
            <meta name="prism.keyword" content="lesion-directed therapy ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/06/01">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="690">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12837.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-690">
            <meta name="citation_title" content="Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas">
            <meta name="citation_abstract" content="Cutaneous squamous cell carcinoma (SCC) is among the most common cancers in humans, and many patients with SCC will develop multiple tumors within their lifetime. The field cancerization concept, originally proposed over 60 years ago, hypothesized that multiple primary cancers may arise simultaneously and coexist with subclinical precursor lesions within a defined field. Genetic sequencing of SCC and precursor lesions has identified what may be the earliest clonal proliferations in SCC development and confirmed that field cancerization in the skin is mediated by ultraviolet radiation. For patients with multiple SCCs and severe actinic damage, treatment of precursor lesions within a cancerized field can decrease the risk of subsequent cancer development. Sunblock is an effective intervention for field cancerization, even in patients with established disease. There is now direct evidence that field therapy with topical 5-fluorouracil is effective in reducing the incidence of subsequent SCC, and there is indirect evidence suggesting that topical imiquimod, topical ingenol mebutate, and photodynamic therapy are similarly effective. There is limited direct evidence to show that systemic acitretin or nicotinamide can decrease incident SCC in patients with field cancerization. In this review, an approach to the management of patients with multiple SCCs and field cancerization is presented along with the rationale to support field-directed therapy.">
            <meta name="citation_description" content="Cutaneous squamous cell carcinoma (SCC) is among the most common cancers in humans, and many patients with SCC will develop multiple tumors within their lifetime. The field cancerization concept, originally proposed over 60 years ago, hypothesized that multiple primary cancers may arise simultaneously and coexist with subclinical precursor lesions within a defined field. Genetic sequencing of SCC and precursor lesions has identified what may be the earliest clonal proliferations in SCC development and confirmed that field cancerization in the skin is mediated by ultraviolet radiation. For patients with multiple SCCs and severe actinic damage, treatment of precursor lesions within a cancerized field can decrease the risk of subsequent cancer development. Sunblock is an effective intervention for field cancerization, even in patients with established disease. There is now direct evidence that field therapy with topical 5-fluorouracil is effective in reducing the incidence of subsequent SCC, and there is indirect evidence suggesting that topical imiquimod, topical ingenol mebutate, and photodynamic therapy are similarly effective. There is limited direct evidence to show that systemic acitretin or nicotinamide can decrease incident SCC in patients with field cancerization. In this review, an approach to the management of patients with multiple SCCs and field cancerization is presented along with the rationale to support field-directed therapy.">
            <meta name="citation_keywords" content="cutaneous squamous cell carcinoma, field cancerization, lesion-directed therapy ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Sean R. Christensen">
            <meta name="citation_author_institution" content="Section of Dermatologic Surgery and Cutaneous Oncology, Department of Dermatology, Yale University, New Haven, CT, USA">
            <meta name="citation_publication_date" content="2018/06/01">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="690">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12837.1">
            <meta name="citation_firstpage" content="690">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-690/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-690.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13910 /> <input type=hidden id=articleId name=articleId value=12837 /> <input type=hidden id=xmlUrl value="/articles/7-690/v1/xml"/> <input type=hidden id=xmlFileName value="-7-690-v1.xml"> <input type=hidden id=article_uuid value=ffa282c2-0b8e-43d9-88c7-0dc7efd2f29e /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12837.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12837.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-690"
  },
  "headline": "Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas",
  "datePublished": "2018-06-01T15:09:24",
  "dateModified": "2018-06-01T15:09:24",
  "author": [
    {
      "@type": "Person",
      "name": "Sean R. Christensen"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Cutaneous squamous cell carcinoma (SCC) is among the most common cancers in humans, and many patients with SCC will develop multiple tumors within their lifetime. The field cancerization concept, originally proposed over 60 years ago, hypothesized that multiple primary cancers may arise simultaneously and coexist with subclinical precursor lesions within a defined field. Genetic sequencing of SCC and precursor lesions has identified what may be the earliest clonal proliferations in SCC development and confirmed that field cancerization in the skin is mediated by ultraviolet radiation. For patients with multiple SCCs and severe actinic damage, treatment of precursor lesions within a cancerized field can decrease the risk of subsequent cancer development. Sunblock is an effective intervention for field cancerization, even in patients with established disease. There is now direct evidence that field therapy with topical 5-fluorouracil is effective in reducing the incidence of subsequent SCC, and there is indirect evidence suggesting that topical imiquimod, topical ingenol mebutate, and photodynamic therapy are similarly effective. There is limited direct evidence to show that systemic acitretin or nicotinamide can decrease incident SCC in patients with field cancerization. In this review, an approach to the management of patients with multiple SCCs and field cancerization is presented along with the rationale to support field-directed therapy."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-690.html",
            "name": "Recent advances in field cancerization and management of multiple..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in field cancerization and management of multiple... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13910 data-id=12837 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12837.1" data-recommended="" data-doi="10.12688/f1000research.12837.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-690/v1/pdf?article_uuid=ffa282c2-0b8e-43d9-88c7-0dc7efd2f29e" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12837-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12837-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12837-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Christensen SR. Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):690 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12837.1" target=_blank>https://doi.org/10.12688/f1000research.12837.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12837-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12837 id=track-article-signin-12837 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12837?target=/articles/7-690.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13910 /> <input name=articleId type=hidden value=12837 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:Sean.Christensen@yale.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sean R. Christensen</span></a><a href="https://orcid.org/0000-0003-2711-0026" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-2711-0026</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:Sean.Christensen@yale.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sean R. Christensen</span></a><a href="http://orcid.org/0000-0003-2711-0026" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-2711-0026</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 01 Jun 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12837.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Section of Dermatologic Surgery and Cutaneous Oncology, Department of Dermatology, Yale University, New Haven, CT, USA<br/> <p> <div class=margin-bottom> Sean R. Christensen <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=11834-34407></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=34845-34408></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Cutaneous squamous cell carcinoma (SCC) is among the most common cancers in humans, and many patients with SCC will develop multiple tumors within their lifetime. The field cancerization concept, originally proposed over 60 years ago, hypothesized that multiple primary cancers may arise simultaneously and coexist with subclinical precursor lesions within a defined field. Genetic sequencing of SCC and precursor lesions has identified what may be the earliest clonal proliferations in SCC development and confirmed that field cancerization in the skin is mediated by ultraviolet radiation. For patients with multiple SCCs and severe actinic damage, treatment of precursor lesions within a cancerized field can decrease the risk of subsequent cancer development. Sunblock is an effective intervention for field cancerization, even in patients with established disease. There is now direct evidence that field therapy with topical 5-fluorouracil is effective in reducing the incidence of subsequent SCC, and there is indirect evidence suggesting that topical imiquimod, topical ingenol mebutate, and photodynamic therapy are similarly effective. There is limited direct evidence to show that systemic acitretin or nicotinamide can decrease incident SCC in patients with field cancerization. In this review, an approach to the management of patients with multiple SCCs and field cancerization is presented along with the rationale to support field-directed therapy. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> cutaneous squamous cell carcinoma, field cancerization, lesion-directed therapy </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Sean R. Christensen (<a href="mailto:Sean.Christensen@yale.edu">Sean.Christensen@yale.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Sean R. Christensen </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Christensen SR. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Christensen SR. Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):690 (<a href="https://doi.org/10.12688/f1000research.12837.1" target=_blank>https://doi.org/10.12688/f1000research.12837.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 01 Jun 2018, <b>7</b>(F1000 Faculty Rev):690 (<a href="https://doi.org/10.12688/f1000research.12837.1" target=_blank>https://doi.org/10.12688/f1000research.12837.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 01 Jun 2018, <b>7</b>(F1000 Faculty Rev):690 (<a href="https://doi.org/10.12688/f1000research.12837.1" target=_blank>https://doi.org/10.12688/f1000research.12837.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d38622e138>Introduction</h2><p class="" id=d38622e141>Cutaneous squamous cell carcinoma (SCC) is the second most common malignancy in humans; up to 1 million SCC tumors are treated annually in the United States<sup><a href="#ref-1">1</a></sup>. Over half of patients with diagnosed SCC will develop multiple tumors within their lifetime. Although the majority of SCCs of the skin are localized tumors with an exceptionally good prognosis, approximately 5% of SCCs recur locally after definitive treatment, 2–3% exhibit nodal metastasis, and 1–2% are fatal<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. In addition to causing between 4,000 and 9,000 deaths annually, SCC and its associated skin lesions have an enormous financial burden at over $4 billion per year in the United States<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d38622e159>Cutaneous SCC typically presents in older patients on chronically sun-exposed skin as a scaly erythematous papule that may have ulceration and hemorrhagic crust. Some lesions have more pronounced hyperkeratosis, and larger lesions may exhibit a central core of hard keratin and hemorrhagic debris (<a href="#f1">Figure 1a</a>). Lesions may bleed or be tender to palpation but often are asymptomatic. SCC <i>in situ</i> is an intra-epidermal malignancy (not breaching the basement membrane) that often presents as a pink scaly plaque (<a href="#f1">Figure 1b</a>) and has a low but reported risk of progression to invasive SCC<sup><a href="#ref-5">5</a></sup>. Although the classic presentation of SCC is a solitary lesion, some patients present with multiple lesions that may be admixed with premalignant lesions known as actinic keratoses (<a href="#f2">Figure 2</a>). In these patients, lesion-directed therapy of dozens of individual neoplasms does not adequately address their underlying pathology, which is best described as field cancerization. This review will focus on recent developments in the pathogenesis and management of patients with multiple cutaneous SCCs and field cancerization.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13910/db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure1.gif"><img alt="db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13910/db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure1.gif"></a><div class=caption><h3>Figure 1. Clinical presentation of squamous cell carcinoma (SCC) and SCC <i>in situ</i>.</h3><p id=d38622e191>(<b>a</b>) Invasive SCC presenting as a firm ulcerated lesion with central core of keratinaceous and hemorrhagic debris on the preauricular cheek. (<b>b</b>) SCC <i>in situ</i> presenting as multi-focal and poorly demarcated pink scaly plaques on the dorsal forearm.</p></div></div><a name=f2 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13910/db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure2.gif"><img alt="db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13910/db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure2.gif"></a><div class=caption><h3>Figure 2. Clinical presentation of field cancerization.</h3><p id=d38622e217>(<b>a</b>) Squamous cell carcinoma (SCC) <i>in situ</i> (circled lesion) presenting on the scalp with chronic actinic damage and innumerable small, gritty actinic keratoses. It is not clear which lesions are precursors and which may have progressed to SCC. (<b>b</b>) SCC (circled lesion) presenting on the forehead in close proximity to three additional lesions. Two of the satellite lesions were SCC <i>in situ</i> that was discontiguous with the primary SCC, suggesting simultaneous but independent development of the lesions.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d38622e239>Lesion-directed therapy of squamous cell carcinoma</h2><p class="" id=d38622e242>Cutaneous SCC is most commonly treated with lesion-directed therapy using surgical excision or destruction. Standard excision with an appropriate margin of clinically normal skin (typically 4–6 mm) or destruction with electrodesiccation and curettage results in cure rates as high as 90–95% for typical SCC<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. SCC with significant subclinical extension, or local invasion of the tumor beyond grossly visible margins, is best treated with Mohs micrographic surgery, a specialized method of staged excision in which the entire deep and peripheral surgical margin is microscopically examined by the surgeon with rapid intra-operative pathology<sup><a href="#ref-8">8</a></sup>. Established risk factors for subclinical extension and aggressive behavior of SCC include recurrent tumors, tumor diameter greater than 2 cm, depth of invasion greater than 6 mm, poorly differentiated or desmoplastic histologic features, perineural invasion, immunosuppression, and tumor location on the scalp, ears, eyelid, nose, or lip<sup><a href="#ref-9">9</a>–<a href="#ref-11">11</a></sup>. The superiority of Mohs micrographic surgery over standard excision for these high-risk tumors has been documented in retrospective studies<sup><a href="#ref-12">12</a></sup>, and the Mohs technique is currently recommended for SCC with high-risk features or in anatomically sensitive locations<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d38622e271>For SCC not amenable to surgery, non-surgical treatments may be used, albeit with lower cure rates. Topical medical therapy of individual SCC <i>in situ</i> lesions with either imiquimod or 5-fluorouracil (5FU) has been reported with cure rates of 73–86% and 48–69%, respectively<sup><a href="#ref-14">14</a>–<a href="#ref-17">17</a></sup>, but neither of these treatments is consistently effective for invasive SCC. Similarly, photodynamic therapy (PDT) with either aminolevulinic acid or methyl aminolevulinate may achieve clinical cure rates of 76–82% for SCC <i>in situ</i><sup><a href="#ref-16">16</a>–<a href="#ref-18">18</a></sup>. Lesion-directed cryotherapy with liquid nitrogen (a form of physical destruction of the lesion) is commonly used for low-risk SCC <i>in situ</i> and precursor lesions of actinic keratosis (AK). Although cryotherapy is highly operator-dependent, one trial reported a complete response rate for SCC <i>in situ</i> of 67% at 1 year, which was comparable to 5FU and inferior to PDT<sup><a href="#ref-17">17</a></sup>. Intra-lesional chemotherapy (direct local injection into the tumor) with agents such as 5FU, methotrexate, bleomycin, or type I interferon has successfully treated SCC in several published case series, often specifically addressing the keratoacanthoma type of SCC that is characterized by rapid growth and occasional spontaneous involution<sup><a href="#ref-19">19</a></sup>. Because intra-lesional chemotherapy has not been studied in controlled clinical trials, its use is often reserved for patients who are poor surgical candidates or who have such a high burden of individual lesions that surgery is not practical. Although medical treatment of SCC has decreased efficacy for individual lesions relative to surgery, several of these modalities have the benefit of potentially treating a broad field around the index lesion, which may inhibit the development of subsequent SCC. Patients with multiple SCCs often benefit from a combination of medical and surgical field-directed and lesion-directed treatment approaches as discussed below.</p><p class="" id=d38622e308>Radiation therapy has long been employed in the treatment of SCC and may be preferable to surgical treatment in specific circumstances. Low-risk SCC treated with superficial X-ray therapy has a reported 5-year recurrence rate of 5.8% in one series<sup><a href="#ref-20">20</a></sup>. Treatment of larger SCCs, poorly differentiated tumors, or tumors on the scalp, ears, or lips with superficial radiation may result in increased recurrence rates of up to 30%<sup><a href="#ref-21">21</a></sup>. More intense radiation therapy with electron beam or megavoltage photons has been reported as monotherapy for advanced SCC, but high-quality outcome data are lacking<sup><a href="#ref-22">22</a></sup>. In addition, because of the risk of secondary malignancy decades after radiation therapy, this treatment is relatively contraindicated in younger patients with a long life expectancy. Finally, advanced SCC with lymph node or visceral metastasis is best managed with multi-modal therapy, including surgery, radiation, and potentially systemic chemotherapy. More recently, immunotherapy with monoclonal antibodies to the immune checkpoint receptor programmed death 1 (PD-1) on T cells has been reported as a successful treatment to induce T cell-mediated rejection of advanced SCC that is unresponsive to standard therapy<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>. Whether this therapy can be adapted for patients with multiple primary SCCs remains to be determined.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d38622e333>Field cancerization</h2><p class="" id=d38622e336>In 1953, Slaughter and colleagues described the concept of field cancerization on the basis of their study of pathologic changes in the epithelium surrounding oropharyngeal SCC<sup><a href="#ref-25">25</a></sup>. In that seminal report, the authors observed that all cases of oropharyngeal SCC had pathologic dysplasia and foci of SCC <i>in situ</i> in the adjacent mucosa that was grossly normal (no clinical evidence of disease). Importantly, many of these changes were not contiguous with the primary tumor and represented separate islands of dysplastic epithelium. In addition, 11% of oropharyngeal SCCs presented with two separate primary lesions, a rate 10-fold greater than expected on the basis of disease prevalence. Together, these findings support the independent or co-incident development of multiple lesions rather than the linear progression of a single mutant clone. The paradigm of field cancerization was thus proposed on the basis of the hypothesis that an area, or field, of epithelium is altered by a regional carcinogenic activity. This regional injury, which may be acute or chronic, causes irreversible genetic changes in multiple clonal populations of cells, one or several of which eventually manifest in cancer.</p><p class="" id=d38622e346>Although this concept of field cancerization has long been observed in the skin, Slaughter’s original pathologic findings were recently recapitulated for cutaneous SCC. In excision specimens of cutaneous SCC, 57% had separate (discontiguous) foci of dysplasia that were not detected clinically but were pathologically diagnostic of AK<sup><a href="#ref-26">26</a></sup>. In addition, both histopathologic biopsies and non-invasive imaging with optical coherence tomography of cutaneous regions of suspected field cancerization confirmed that 79% of grossly normal skin samples in these fields had evidence of dysplasia or occult carcinoma<sup><a href="#ref-27">27</a></sup>. The field cancer paradigm has two important implications for the management of cutaneous SCC. First, because SCC arises from multi-focal areas of precancerous change, the presence of at least one SCC confers an increased risk of subsequent SCC. It has been shown that after a single SCC, there is a 42% risk of subsequent SCC within 5 years and this risk increases to 72% in patients with two or more SCCs<sup><a href="#ref-28">28</a></sup>. Second, clinical recurrence of SCC after complete surgical excision may in fact represent the development of a new primary cancer, and recurrence risk may correlate with the degree of field cancerization. Indeed, it was found that patients with two to nine SCCs exhibit a twofold increased risk of recurrence compared with patients with a single SCC, and patients with a lifetime history of 10 or more SCCs exhibit a 12-fold increased risk of local recurrence as well as an 11-fold increased risk of nodal metastasis<sup><a href="#ref-29">29</a></sup>. In these patients with a heavy burden of individual cancers, understanding the mechanism of field cancerization and SCC evolution from precursor lesions has spurred development of therapeutic strategies to prevent or suppress the development of subsequent SCC.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d38622e368>Precursor lesions and the mechanistic basis of field cancer</h2><p class="" id=d38622e371>The primary driver of epidermal carcinogenesis is solar ultraviolet (UV) radiation. Epidemiologic studies have demonstrated a 10-fold increase in SCC incidence with increasing ambient solar radiation<sup><a href="#ref-30">30</a></sup>. From a mechanistic standpoint, UV radiation directly (primarily UVB wavelengths, 290–320 nm) and indirectly (primarily UVA wavelengths, 320–400 nm) damages epidermal DNA, leading to somatic mutations in genes that confer a growth advantage and facilitate malignant transformation<sup><a href="#ref-31">31</a></sup>. Somatic mutations, both inactivating mutations in tumor suppressor genes and activating mutations in oncogenes, accumulate over time in a sequential fashion. According to the model of multi-step carcinogenesis, increasing somatic mutations induce clonal proliferations that progress from microscopic precursors to grossly visible lesions during the development of carcinoma<sup><a href="#ref-32">32</a></sup>. A second mechanistic effect of UV radiation is local immunosuppression that facilitates epidermal carcinogenesis. Studies in human volunteers have defined both acute and chronic effects of UVB in inhibiting adaptive immune responses to contact allergens applied to the skin and shown that this UV-mediated immunosuppression correlates with SCC risk<sup><a href="#ref-33">33</a></sup>. Given the established association of therapeutic immunosuppression (for example, in organ transplant recipients) with dramatically increased SCC risk, it is clear that effective anti-tumor immunity plays an important role in limiting the progression of precursor lesions in the skin.</p><p class="" id=d38622e390>The most characteristic precursor lesion in the skin is AK, a small papule with gritty scale that has pathologic features of epidermal dysplasia without overt carcinoma. Like SCCs, AKs are causally associated with chronic UV exposure. Although the risk of an individual AK progressing to carcinoma is low, the presence and number of AKs are correlated with SCC risk<sup><a href="#ref-34">34</a>,<a href="#ref-35">35</a></sup>. AK is a clear clinical indicator of field cancer, and some patients may present with dozens of lesions in a single anatomic field, conferring a high risk of subsequent SCC (<a href="#f2">Figure 2a</a>).</p><p class="" id=d38622e403>SCC and its precursor lesions have similar genetic driver mutations, providing further support for the field cancer model. The most commonly described somatic mutations in cutaneous SCC are loss-of-function mutations in the tumor suppressors <i>TP53</i> and <i>NOTCH1</i>, identified in up to 95% and 75% of SCCs, respectively<sup><a href="#ref-36">36</a>–<a href="#ref-38">38</a></sup>. Notably, over three-quarters of somatic mutations in SCC are UV-signature mutations induced by direct interaction of UVB with pyrimidine bases in DNA. Approximately two-thirds of AKs harbor mutations in <i>TP53</i> and these mutations have also been identified in 14% of epidermal cells in sun-exposed but normal skin<sup><a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>. Cells with mutated <i>TP53</i> proliferate in the epidermis as a clonal expansion or “patch” under continuing UV exposure, and animal studies have confirmed that UVB promotes clone expansion but that stopping UVB exposure causes some clones to regress<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. Similarly, <i>NOTCH1</i> mutations are present in clinically and histologically normal skin adjacent to SCC and appear to arise by contiguous growth of a clonal precursor<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d38622e447>Based on these data, a mechanistic model of field cancer emerges, in which initial exposure to UV radiation causes sporadic somatic mutations and subsequent UV exposure induces clonal expansion of these mutants and inhibits immune surveillance of these malignant precursors (<a href="#f3">Figure 3</a>). Competition between mutant clones and normal cells facilitates large patches of mutated cells within an actinically damaged field. Over time, the accumulation of additional mutations will allow progression to visible lesions of AK and eventually SCC. The existence of multiple clones harboring distinct and potentially carcinogenic mutations in normal skin was recently confirmed: deep sequencing of aged eyelid skin identified somatic mutations in 18–32% of epidermal cells, and the total mutation burden was comparable to many adult solid tumors<sup><a href="#ref-43">43</a></sup>. These clonal proliferations are the earliest detectable precursors of SCC and represent targets for therapeutic intervention to prevent subsequent skin cancer. What remains unknown, however, is whether specific variables such as the frequency, size, total mutation burden, or specific mutation profile of these clones determine the magnitude of SCC risk.</p><a name=f3 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13910/db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure3.gif"><img alt="db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13910/db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure3.gif"></a><div class=caption><h3>Figure 3. Pathogenesis of field cancerization.</h3><p id=d38622e468>Ultraviolet (UV) radiation directly induces mutation in a single keratinocyte. If this mutation provides a selective growth advantage, such as with loss of functional <i>TP53</i>, ongoing UV exposure will facilitate expansion of the clone as well as inhibit immune-mediated surveillance. Chronic UV exposure results in development and expansion of additional clones that evolve and compete with normal cells and each other in a field of actinically damaged skin. Accumulation of additional mutations over time and ongoing UV exposure will allow progression of a microscopic subclone into a visible actinic keratosis and eventually invasive squamous cell carcinoma.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d38622e481>Management of field cancerization</h2><p class="" id=d38622e484>The first step in the management of the patient with multiple SCCs and field cancerization is rigorous sun protection. Because UV radiation is both a tumor initiator and a tumor promoter for skin cancer and because animal models demonstrate reduced precursor lesions when UV exposure is interrupted<sup><a href="#ref-42">42</a></sup>, there is a strong incentive to limit exposure even in patients with established actinic damage. The most compelling data to support sun protection come from randomized trials performed in Australia, a region of intense environmental UV radiation and a susceptible population with the greatest incidence of SCC worldwide. In 1993, Thompson and colleagues randomly assigned 588 patients with established AK to daily use of either sun protection factor (SPF) 17 broad-spectrum sunblock (UVA and UVB protection) or placebo cream. Patients who received sunblock had a significant reduction in new AK, and this reduction was proportional to the total amount of sunblock used<sup><a href="#ref-44">44</a></sup>. Of note, the use of a placebo sunblock would likely be considered unethical in 2018, but the benefits of sunblock were not yet established at the time of the trial. A second trial randomly assigned 1,621 unselected participants to one of four treatments: daily use of SPF 15 broad-spectrum sunblock, discretionary use of sunblock, daily sunblock plus oral beta-carotene, and oral beta-carotene alone with discretionary use of sunblock. Over a follow-up period of 4 years, daily sunblock use caused a significant 39% reduction in new SCC; the use of beta-carotene had no effect on skin cancer development<sup><a href="#ref-45">45</a></sup>. Follow-up of these participants for an additional 8 years revealed a persistent 41% reduction in new SCC in the former daily sunblock group, even when returning to discretionary sunblock use after completion of the original trial<sup><a href="#ref-46">46</a></sup>. Finally, there is an important role for sun protection in immunosuppressed organ transplant recipients as well. In a 24-month trial of organ transplant recipients at high risk of SCC, patients provided with SPF 50 broad-spectrum sunblock developed fewer SCCs (eight in the control group versus zero in the sunblock group) and exhibited a significant regression of existing AK<sup><a href="#ref-47">47</a></sup>. Cumulatively, this suggests that rigorous sun protection will have significant and long-lasting benefits in both prevention and management of field cancerization.</p><p class="" id=d38622e507>Apart from sun protection, the most widely used field-directed treatments are topical medications such as the pyrimidine analog chemotherapeutic 5FU. For many years, the observation that SCC precursors can be effectively treated with topical therapy provided the rationale for field treatment to decrease the incidence of SCC in high-risk patients. There is strong evidence to support the use of 5FU and other topical agents, such as the immune response modifier imiquimod and the non-steroidal anti-inflammatory drug diclofenac in the treatment of AK. Clinical evidence for these agents in AK treatment is extensive and beyond the scope of this review<sup><a href="#ref-48">48</a></sup>. The hypothesis that treatment of precursor lesions within a cancerized field can reduce subsequent SCC development is supported by several lines of indirect evidence and, more recently, a clinical trial that documented clear efficacy of 5FU in SCC prevention. First, there is a proven benefit of field therapy over lesion-directed therapy for sustained clearance of AK within a defined field. One randomized trial found that although 5FU, imiquimod, or lesion-directed destructive therapy all had good immediate efficacy in AK clearance (68–96%), only field therapy with 5FU or imiquimod produced any significant clearance at 1 year (33% and 73%, respectively, versus 4% for lesion-directed therapy)<sup><a href="#ref-49">49</a></sup>. Second, long-term follow-up of patients randomly assigned to 5FU field therapy versus placebo demonstrated that the benefits of sustained lesion clearance are significant for over 3 years following a single treatment course, suggesting that topical field therapy produces a long-lasting remission in SCC precursors<sup><a href="#ref-50">50</a></sup>. Third, a recent randomized, double-blind clinical trial in 932 patients with a history of skin cancer (39% of whom had prior SCC) identified a 75% reduction in incident SCC in the first year following a single course of topical 5FU treatment (five patients with SCC in the 5FU group versus 20 patients in the placebo group)<sup><a href="#ref-51">51</a></sup>. This study is the first high-quality, prospective trial to demonstrate a significant reduction in SCC with field therapy and provides strong support for the concept of field-directed therapy in high-risk patients. Finally, preclinical and early clinical data suggest that topical 5FU can be combined with topical immunotherapy to enhance field-directed prevention of SCC. Topical calcipotriol, a vitamin D derivative shown to enhance cutaneous T-cell activation via the production of thymic stromal lymphopoietin (TSLP), can reduce the development of SCC in animal models and was shown to enhance the efficacy of AK clearance with 5FU in a preliminary human trial<sup><a href="#ref-52">52</a></sup>.</p><p class="" id=d38622e530>Another topical field therapy has recently emerged in the form of ingenol mebutate, a cyclic diterpene ester derived from the sap of the <i>Euphorbia peplus</i> plant, which itself is a known irritant and established botanical therapeutic<sup><a href="#ref-53">53</a></sup>. Ingenol mebutate has direct cytotoxic effects on keratinocytes and induces a local inflammatory milieu via effects on the microvasculature and endothelial cells. Unlike other topical therapies, a short, 2- to 3-day treatment with ingenol mebutate has demonstrated efficacy in field treatment of AK, which may improve patient compliance<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>. Via elimination of SCC precursors such as <i>TP53</i>-mutated clones in the epidermis, ingenol mebutate can prevent or reduce the development of UV-induced lesions in an animal model of SCC<sup><a href="#ref-56">56</a></sup>. Similarly, ingenol mebutate therapy in humans has been shown to decrease not only visible AK but also subclinical precursor lesions detected by optical coherence tomography and histopathologic analysis<sup><a href="#ref-27">27</a></sup>. Although it appears likely that various topical agents such as ingenol mebutate and imiquimod can decrease the incidence of subsequent SCC in patients with field cancer, direct evidence of this effect is currently available only for 5FU<sup><a href="#ref-51">51</a></sup>.</p><p class="" id=d38622e563>An established option for field-directed treatment is office-based PDT. PDT is based on photo-activation of protoporphyrin IX in keratinocytes to generate reactive oxygen species and cytotoxicity. A prodrug (aminolevulinic acid or methyl aminolevulinate) is topically applied to the skin 1–18 hours prior to visible-spectrum light treatment, and because metabolic conversion of the prodrug to protoporphyrin IX is enhanced in malignant and pre-malignant cells, this treatment is relatively selective for SCC precursors in the skin<sup><a href="#ref-57">57</a></sup>. Analogous to the topical therapies presented above, PDT is an effective field treatment for AK and is superior to lesion-directed destructive therapy<sup><a href="#ref-58">58</a></sup>. Like other field treatments, PDT can significantly reduce the size and number of <i>TP53</i>-mutated clonal precursors of SCC in human skin<sup><a href="#ref-59">59</a></sup> and has been demonstrated to decrease UV-induced tumor development in animal models<sup><a href="#ref-60">60</a></sup>. Because PDT (and presumably other current field therapy options) does not completely eliminate mutated precursors from the skin, repeated treatments appear to be required to continually suppress the development of SCC. One observational study of 12 organ transplant recipients with high-risk field cancer treated with cyclic PDT every 4–8 weeks reported 79% and 95% reductions in incident SCC after 1 and 2 years, respectively, compared with the year prior to cyclic PDT<sup><a href="#ref-61">61</a></sup>. In contrast, a prospective trial of 40 patients who received a single course of PDT found no significant decrease in SCC incidence after 2 years<sup><a href="#ref-62">62</a></sup>. The optimal interval for cyclic therapy may be better defined by an ongoing trial investigating cyclic PDT every 6 months in organ transplant recipients at elevated risk for skin cancer; interim results of the trial have not yet detected any incident SCC<sup><a href="#ref-63">63</a></sup>. If repeated treatments are required, one promising new alternative could be daylight PDT, in which photo-activation of protoporphyrin IX is achieved by natural daylight as opposed to more intense (and often more painful) artificial light sources. Although daylight PDT appears promising for the treatment of AK<sup><a href="#ref-64">64</a></sup>, its effect on SCC prevention has not been investigated.</p><p class="" id=d38622e603>For patients with severe field damage at highest risk for subsequent SCC, systemic treatment may dramatically inhibit new tumor development. Acitretin is a systemic retinoid known to suppress proliferation and promote differentiation of keratinocytes and has been shown to induce regression of SCC-like tumors in animal models<sup><a href="#ref-65">65</a></sup>. Compelling evidence to support acitretin as field therapy comes from a prospective trial of 44 renal transplant recipients randomly assigned to either acitretin 30 mg daily or placebo for 6 months. Incident SCC was reduced by 88% in patients during acitretin treatment, although the rate of SCC development increased to the same as the control group in the 6 months following discontinuation of therapy<sup><a href="#ref-66">66</a></sup>. Similar to PDT or topical therapy, field treatment with acitretin suppresses the development of SCC but does not completely eliminate clonal precursors of SCC and thus therapy must be continued for a prolonged period of time. Systemic side effects from acitretin can be significant but are predictable and often dose-dependent, including xerosis, mucositis, myalgias and arthralgias, hyperlipidemia, and potential hepatotoxicity. Acitretin, like all systemic retinoids, is an established teratogen and should be avoided in women of child-bearing potential because of its long half-life. Isotretinoin has a significantly shorter half-life and may be an alternative for younger women, although it is rare for this population to require systemic field therapy<sup><a href="#ref-67">67</a></sup>. It should also be noted that the beneficial effects of systemic therapy are less pronounced in patients at lower risk for SCC and this therapy should be reserved for patients with few other options<sup><a href="#ref-68">68</a></sup>.</p><p class="" id=d38622e622>At least two other approaches for systemic field therapy may also be considered. First, nicotinamide (also known as niacinamide, the amide form of vitamin B<sub>3</sub>) has recently been shown to have modest preventive effects on UV-induced skin lesions, presumably by promoting effective DNA repair and reducing the immunosuppressive effects of UV exposure<sup><a href="#ref-69">69</a></sup>. In a prospective trial of 386 patients with prior skin cancer, those randomly assigned to oral nicotinamide 500 mg twice daily had a 23% reduction in new skin cancers (30% reduction in SCC) during 12 months of therapy. When patients were monitored for 6 months after cessation of nicotinamide therapy, there was a non-significant trend toward increased SCC incidence during this period<sup><a href="#ref-70">70</a></sup>. Although nicotinamide produced only a modest reduction in SCC incidence, the lack of significant side effects associated with this agent makes it a potentially useful option, either alone or in combination with other field therapies. Second, capecitabine, an oral prodrug of 5FU that is US Food and Drug Administration-approved for the treatment of colorectal, gastric, and breast cancer, may be an effective prophylactic measure for patients with recalcitrant field cancerization. In one uncontrolled observational study, cyclic treatment with capecitabine produced a 68% reduction in incident SCC<sup><a href="#ref-71">71</a></sup>. Because of the significant side effect profile of this systemic chemotherapy, treatment of cutaneous field cancerization with capecitabine is usually performed in conjunction with a medical oncologist.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d38622e644>Approach to the patient with field cancerization</h2><p class="" id=d38622e647>In order to appropriately manage patients with cutaneous field cancer, it is necessary to define this term. A practical working definition of field cancerization requires three features: a defined region of skin, multiple AKs within that region, and at least one prior SCC. Although patients with severe actinic damage and multiple AKs without prior SCC may certainly require treatment for their AKs<sup><a href="#ref-72">72</a></sup>, those patients are not considered here. The type, frequency, and intensity of field treatment for an individual patient depend on the severity of field cancerization and the risk of subsequent SCC (<a href="#f4">Figure 4</a>). All patients with evidence of field cancerization should be counseled on rigorous sun protection and have appropriate lesion-directed therapy of SCC and hypertrophic AK as indicated. Patients with multiple AKs and few sporadic SCCs are at relatively low risk of subsequent SCC and can be managed with occasional field therapy according to patient or physician preference. This may include topical 5FU, imiquimod, or ingenol mebutate, or PDT. Patients with a consistent pattern of two or three SCCs per year are at increased risk of continual SCC development and will require repeated cycles of field therapy at some interval ranging from annually to every few months. As noted previously, current field therapies suppress, rather than completely eliminate, the precursors of SCC; repeated treatments are often required for ongoing suppression. A combination of simultaneous field therapy and lesion-directed therapy in these patients may also improve local control<sup><a href="#ref-73">73</a></sup>. Those not responding to PDT or topical therapy may benefit from systemic acitretin. Patients with more than three or four SCCs per year or more than 10 lifetime SCCs, as noted previously, are at high risk of both subsequent SCC and metastatic or fatal SCC and require aggressive field therapy. Initial therapy in these patients is often systemic acitretin, which may be combined with repeated topical therapy or PDT. Combination treatments may have synergistic efficacy, as reported in one recent series of combined lesion-directed destruction, topical 5FU, and PDT<sup><a href="#ref-74">74</a></sup>. Combination systemic therapy with nicotinamide and acitretin is generally accepted as safe, but concurrent use of acitretin and capecitabine has not been studied and should be used with caution. Finally, organ transplant recipients require additional focus on management of field cancer, as the chronic use of immunosuppressant medications places these patients at exceptionally high risk of multiple and biologically aggressive SCCs<sup><a href="#ref-75">75</a></sup>. Organ transplant recipients often require more frequent monitoring, earlier initiation of multi-modal field therapy, and potentially modification of their immunosuppression regimen in collaboration with their transplant team.</p><a name=f4 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13910/db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure4.gif"><img alt="db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure4.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13910/db6a716d-0ff4-4ee4-b395-f0c2e27cfa68_figure4.gif"></a><div class=caption><h3>Figure 4. Approach to the patient with field cancerization.</h3><p id=d38622e679>Field cancer treatment is based on risk of subsequent squamous cell carcinoma (SCC), as determined by clinical factors. All patients require ultraviolet (UV) protection and lesion-directed therapy as indicated. AK, actinic keratosis; PDT, photodynamic therapy.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d38622e689>Conclusions and future directions</h2><p class="" id=d38622e692>Significant progress has been made in understanding the pathogenesis and optimal management of field cancerization, yet several questions remain. It is clear that patients with a large burden of cutaneous SCC have a chronic disease with an increased risk of systemic involvement and early death; treating each lesion as an isolated neoplasm does not adequately address this disease. A systemic and systematic approach to field therapy is required for these patients. It is also clear that SCC evolves from microscopic precursors harboring carcinogenic mutations in grossly normal skin and that a significant fraction of epidermal cells may harbor these mutations in an actinically damaged field. It remains unclear, however, whether the number, size, total mutation burden, or specific mutation profile of these precursors is the critical determinant of progression to SCC. With additional data from genetic sequencing of normal but sun-exposed skin, it may be possible to more accurately determine the risk of SCC development, both for a single precursor lesion and for a cancerized field as a whole. Similarly, nearly all patients with more than 10 SCCs presented initially with a single lesion, yet current methods cannot prospectively determine subsequent field cancer risk. Additional study is required to identify those patients who would benefit most from field treatment at an early point in their field disease progression. Although there is now high-quality evidence to show that field treatment with topical 5FU can reduce the incidence of SCC for at least 1 year, additional clinical trials are needed to support the use of other therapies and the optimal interval of repeated field therapy for high-risk patients. Finally, anti-tumor immunity has been shown to be a critical factor in host defense against cancer, but the role of the immune response in the development and progression of precursor lesions has only been suggested. Future field treatments may more effectively harness the immune system to achieve a durable suppression of SCC development in a cancerized field.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d38622e1 class=n-a></a><h2 class=main-title id=d38864>Competing interests</h2><p class=metadata-entry><a name=d38622e75 class=n-a></a><p id=d38622e76> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d38622e1 class=n-a></a><h2 class=main-title id=d38866>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d38622e699 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d39104>References</h2><div class="section ref-list"><a name=d38622e699 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d38622e706 class=n-a></a>Rogers HW, Weinstock MA, Feldman SR, <i> et al.</i>: Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. <i>JAMA Dermatol.</i> 2015; <b>151</b>(10): 1081–6. <a target=xrefwindow id=d38622e717 href="http://www.ncbi.nlm.nih.gov/pubmed/25928283">PubMed Abstract </a> | <a target=xrefwindow id=d38622e720 href="http://dx.doi.org/10.1001/jamadermatol.2015.1187">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d38622e729 class=n-a></a>Schmults CD, Karia PS, Carter JB, <i> et al.</i>: Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. <i>JAMA Dermatol.</i> 2013; <b>149</b>(5): 541–7. <a target=xrefwindow id=d38622e740 href="http://www.ncbi.nlm.nih.gov/pubmed/23677079">PubMed Abstract </a> | <a target=xrefwindow id=d38622e743 href="http://dx.doi.org/10.1001/jamadermatol.2013.2139">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718014573"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e752 class=n-a></a>Karia PS, Han J, Schmults CD: Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. <i>J Am Acad Dermatol.</i> 2013; <b>68</b>(6): 957–66. <a target=xrefwindow id=d38622e760 href="http://www.ncbi.nlm.nih.gov/pubmed/23375456">PubMed Abstract </a> | <a target=xrefwindow id=d38622e763 href="http://dx.doi.org/10.1016/j.jaad.2012.11.037">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718014573">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d38622e776 class=n-a></a>Lim HW, Collins SAB, Resneck JS Jr, <i> et al.</i>: The burden of skin disease in the United States. <i>J Am Acad Dermatol.</i> 2017; <b>76</b>(5): 958–972.e2. <a target=xrefwindow id=d38622e787 href="http://www.ncbi.nlm.nih.gov/pubmed/28259441">PubMed Abstract </a> | <a target=xrefwindow id=d38622e790 href="http://dx.doi.org/10.1016/j.jaad.2016.12.043">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d38622e799 class=n-a></a>Christensen SR, McNiff JM, Cool AJ, <i> et al.</i>: Histopathologic assessment of depth of follicular invasion of squamous cell carcinoma (SCC) <i>in situ</i> (SCCis): Implications for treatment approach. <i>J Am Acad Dermatol.</i> 2016; <b>74</b>(2): 356–62. <a target=xrefwindow id=d38622e813 href="http://www.ncbi.nlm.nih.gov/pubmed/26670714">PubMed Abstract </a> | <a target=xrefwindow id=d38622e817 href="http://dx.doi.org/10.1016/j.jaad.2015.09.060">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d38622e827 class=n-a></a>Werlinger KD, Upton G, Moore AY: Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation-curettage in a private dermatological practice. <i>Dermatol Surg.</i> 2002; <b>28</b>(12): 1138–42; discussion 1142. <a target=xrefwindow id=d38622e835 href="http://www.ncbi.nlm.nih.gov/pubmed/12472494">PubMed Abstract </a> | <a target=xrefwindow id=d38622e838 href="http://dx.doi.org/10.1046/j.1524-4725.2002.02110.x">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d38622e847 class=n-a></a>Lansbury L, Bath-Hextall F, Perkins W, <i> et al.</i>: Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. <i>BMJ.</i> 2013; <b>347</b>: f6153. <a target=xrefwindow id=d38622e858 href="http://www.ncbi.nlm.nih.gov/pubmed/24191270">PubMed Abstract </a> | <a target=xrefwindow id=d38622e861 href="http://dx.doi.org/10.1136/bmj.f6153">Publisher Full Text </a> | <a target=xrefwindow id=d38622e865 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3816607">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d38622e874 class=n-a></a>Tromovitch TA, Stegeman SJ: Microscopically controlled excision of skin tumors. <i>Arch Dermatol.</i> 1974; <b>110</b>(2): 231–2. <a target=xrefwindow id=d38622e882 href="http://www.ncbi.nlm.nih.gov/pubmed/4853214">PubMed Abstract </a> | <a target=xrefwindow id=d38622e885 href="http://dx.doi.org/10.1001/archderm.1974.01630080033008">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d38622e894 class=n-a></a>Brodland DG, Zitelli JA: Surgical margins for excision of primary cutaneous squamous cell carcinoma. <i>J Am Acad Dermatol.</i> 1992; <b>27</b>(2 Pt 1): 241–8. <a target=xrefwindow id=d38622e902 href="http://www.ncbi.nlm.nih.gov/pubmed/1430364">PubMed Abstract </a> | <a target=xrefwindow id=d38622e905 href="http://dx.doi.org/10.1016/0190-9622(92)70178-I">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d38622e914 class=n-a></a>Leibovitch I, Huilgol SC, Selva D, <i> et al.</i>: Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. <i>J Am Acad Dermatol.</i> 2005; <b>53</b>(2): 261–6. <a target=xrefwindow id=d38622e925 href="http://www.ncbi.nlm.nih.gov/pubmed/16021121">PubMed Abstract </a> | <a target=xrefwindow id=d38622e928 href="http://dx.doi.org/10.1016/j.jaad.2005.03.048">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727835530"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e937 class=n-a></a>Eigentler TK, Leiter U, Häfner HM, <i> et al.</i>: Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study. <i>J Invest Dermatol.</i> 2017; <b>137</b>(11): 2309–15. <a target=xrefwindow id=d38622e948 href="http://www.ncbi.nlm.nih.gov/pubmed/28736229">PubMed Abstract </a> | <a target=xrefwindow id=d38622e951 href="http://dx.doi.org/10.1016/j.jid.2017.06.025">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727835530">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d38622e965 class=n-a></a>Rowe DE, Carroll RJ, Day CL Jr: Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. <i>J Am Acad Dermatol.</i> 1992; <b>26</b>(6): 976–90. <a target=xrefwindow id=d38622e973 href="http://www.ncbi.nlm.nih.gov/pubmed/1607418">PubMed Abstract </a> | <a target=xrefwindow id=d38622e976 href="http://dx.doi.org/10.1016/0190-9622(92)70144-5">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717970943"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e985 class=n-a></a>Ad Hoc Task Force, Connolly SM, Baker DR, <i> et al.</i>: AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. <i>J Am Acad Dermatol.</i> 2012; <b>67</b>(4): 531–50. <a target=xrefwindow id=d38622e996 href="http://www.ncbi.nlm.nih.gov/pubmed/22959232">PubMed Abstract </a> | <a target=xrefwindow id=d38622e999 href="http://dx.doi.org/10.1016/j.jaad.2012.06.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717970943">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d38622e1012 class=n-a></a>Patel GK, Goodwin R, Chawla M, <i> et al.</i>: Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma <i>in situ</i> (Bowen's disease): a randomized, double-blind, placebo-controlled trial. <i>J Am Acad Dermatol.</i> 2006; <b>54</b>(6): 1025–32. <a target=xrefwindow id=d38622e1026 href="http://www.ncbi.nlm.nih.gov/pubmed/16713457">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1030 href="http://dx.doi.org/10.1016/j.jaad.2006.01.055">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d38622e1039 class=n-a></a>Rosen T, Harting M, Gibson M: Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study. <i>Dermatol Surg.</i> 2007; <b>33</b>(4): 427–31; discussion 431–2. <a target=xrefwindow id=d38622e1047 href="http://www.ncbi.nlm.nih.gov/pubmed/17430376">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1050 href="http://dx.doi.org/10.1111/j.1524-4725.2007.33089.x">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d38622e1059 class=n-a></a>Salim A, Leman JA, McColl JH, <i> et al.</i>: Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. <i>Br J Dermatol.</i> 2003; <b>148</b>(3): 539–43. <a target=xrefwindow id=d38622e1070 href="http://www.ncbi.nlm.nih.gov/pubmed/12653747">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1073 href="http://dx.doi.org/10.1046/j.1365-2133.2003.05033.x">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d38622e1082 class=n-a></a>Morton C, Horn M, Leman J, <i> et al.</i>: Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma <i>in situ</i>: Results of a multicenter randomized trial. <i>Arch Dermatol.</i> 2006; <b>142</b>(6): 729–35. <a target=xrefwindow id=d38622e1096 href="http://www.ncbi.nlm.nih.gov/pubmed/16785375">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1100 href="http://dx.doi.org/10.1001/archderm.142.6.729">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d38622e1110 class=n-a></a>Truchuelo M, Fernández-Guarino M, Fleta B, <i> et al.</i>: Effectiveness of photodynamic therapy in Bowen's disease: an observational and descriptive study in 51 lesions. <i>J Eur Acad Dermatol Venereol.</i> 2012; <b>26</b>(7): 868–74. <a target=xrefwindow id=d38622e1121 href="http://www.ncbi.nlm.nih.gov/pubmed/21740466">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1124 href="http://dx.doi.org/10.1111/j.1468-3083.2011.04175.x">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d38622e1133 class=n-a></a>Kirby JS, Miller CJ: Intralesional chemotherapy for nonmelanoma skin cancer: a practical review. <i>J Am Acad Dermatol.</i> 2010; <b>63</b>(4): 689–702. <a target=xrefwindow id=d38622e1141 href="http://www.ncbi.nlm.nih.gov/pubmed/20605654">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1144 href="http://dx.doi.org/10.1016/j.jaad.2009.09.048">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d38622e1153 class=n-a></a>Cognetta AB, Howard BM, Heaton HP, <i> et al.</i>: Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. <i>J Am Acad Dermatol.</i> 2012; <b>67</b>(6): 1235–41. <a target=xrefwindow id=d38622e1164 href="http://www.ncbi.nlm.nih.gov/pubmed/22818756">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1167 href="http://dx.doi.org/10.1016/j.jaad.2012.06.001">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d38622e1176 class=n-a></a>Barysch MJ, Eggmann N, Beyeler M, <i> et al.</i>: Long-term recurrence rate of large and difficult to treat cutaneous squamous cell carcinomas after superficial radiotherapy. <i>Dermatology.</i> 2012; <b>224</b>(1): 59–65. <a target=xrefwindow id=d38622e1187 href="http://www.ncbi.nlm.nih.gov/pubmed/22433440">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1190 href="http://dx.doi.org/10.1159/000337027">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d38622e1199 class=n-a></a>Mendenhall WM, Amdur RJ, Hinerman RW, <i> et al.</i>: Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. <i>Laryngoscope.</i> 2009; <b>119</b>(10): 1994–9. <a target=xrefwindow id=d38622e1210 href="http://www.ncbi.nlm.nih.gov/pubmed/19688856">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1213 href="http://dx.doi.org/10.1002/lary.20608">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726278818"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1222 class=n-a></a>Borradori L, Sutton B, Shayesteh P, <i> et al.</i>: Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases. <i>Br J Dermatol.</i> 2016; <b>175</b>(6): 1382–6. <a target=xrefwindow id=d38622e1233 href="http://www.ncbi.nlm.nih.gov/pubmed/27059424">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1236 href="http://dx.doi.org/10.1111/bjd.14642">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726278818">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726899809"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1250 class=n-a></a>Tran DC, Colevas AD, Chang AL: Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma. <i>JAMA Dermatol.</i> 2017; <b>153</b>(1): 92–4. <a target=xrefwindow id=d38622e1258 href="http://www.ncbi.nlm.nih.gov/pubmed/27784038">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1261 href="http://dx.doi.org/10.1001/jamadermatol.2016.3884">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726899809">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d38622e1274 class=n-a></a>SLAUGHTER DP, SOUTHWICK HW, SMEJKAL W: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. <i>Cancer.</i> 1953; <b>6</b>(5): 963–8. <a target=xrefwindow id=d38622e1282 href="http://www.ncbi.nlm.nih.gov/pubmed/13094644">PubMed Abstract </a> | <a target="xrefwindow" id="d38622e1285" href="http://dx.doi.org/10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515&gt;3.0.CO;2-Q">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726513776"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1294 class=n-a></a>Lanoue J, Chen C, Goldenberg G: Actinic keratosis as a marker of field cancerization in excision specimens of cutaneous malignancies. <i>Cutis.</i> 2016; <b>97</b>(6): 415–20. <a target=xrefwindow id=d38622e1302 href="http://www.ncbi.nlm.nih.gov/pubmed/27416085">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726513776">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733286238"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1315 class=n-a></a>Markowitz O, Schwartz M, Feldman E, <i> et al.</i>: Defining Field Cancerization of the Skin Using Noninvasive Optical Coherence Tomography Imaging to Detect and Monitor Actinic Keratosis in Ingenol Mebutate 0.015%- Treated Patients. <i>J Clin Aesthet Dermatol.</i> 2016; <b>9</b>(5): 18–25. <a target=xrefwindow id=d38622e1326 href="http://www.ncbi.nlm.nih.gov/pubmed/27386042">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1329 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4928476">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733286238">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725351445"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1342 class=n-a></a>Wehner MR, Linos E, Parvataneni R, <i> et al.</i>: Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. <i>JAMA Dermatol.</i> 2015; <b>151</b>(4): 382–8. <a target=xrefwindow id=d38622e1353 href="http://www.ncbi.nlm.nih.gov/pubmed/25588079">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1356 href="http://dx.doi.org/10.1001/jamadermatol.2014.3307">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725351445">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d38622e1369 class=n-a></a>Levine DE, Karia PS, Schmults CD: Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study. <i>JAMA Dermatol.</i> 2015; <b>151</b>(11): 1220–5. <a target=xrefwindow id=d38622e1377 href="http://www.ncbi.nlm.nih.gov/pubmed/26177278">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1380 href="http://dx.doi.org/10.1001/jamadermatol.2015.1702">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d38622e1390 class=n-a></a>Xiang F, Lucas R, Hales S, <i> et al.</i>: Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. <i>JAMA Dermatol.</i> 2014; <b>150</b>(10): 1063–71. <a target=xrefwindow id=d38622e1401 href="http://www.ncbi.nlm.nih.gov/pubmed/25103031">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1404 href="http://dx.doi.org/10.1001/jamadermatol.2014.762">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d38622e1413 class=n-a></a>Pfeifer GP, Besaratinia A: UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. <i>Photochem Photobiol Sci.</i> 2012; <b>11</b>(1): 90–7. <a target=xrefwindow id=d38622e1421 href="http://www.ncbi.nlm.nih.gov/pubmed/21804977">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1424 href="http://dx.doi.org/10.1039/c1pp05144j">Publisher Full Text </a> | <a target=xrefwindow id=d38622e1427 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3289542">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d38622e1436 class=n-a></a>Braakhuis BJ, Tabor MP, Kummer JA, <i> et al.</i>: A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. <i>Cancer Res.</i> 2003; <b>63</b>(8): 1727–30. <a target=xrefwindow id=d38622e1447 href="http://www.ncbi.nlm.nih.gov/pubmed/12702551">PubMed Abstract </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d38622e1456 class=n-a></a>Yoshikawa T, Rae V, Bruins-Slot W, <i> et al.</i>: Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. <i>J Invest Dermatol.</i> 1990; <b>95</b>(5): 530–6. <a target=xrefwindow id=d38622e1467 href="http://www.ncbi.nlm.nih.gov/pubmed/2230216">PubMed Abstract </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d38622e1476 class=n-a></a>Criscione VD, Weinstock MA, Naylor MF, <i> et al.</i>: Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. <i>Cancer.</i> 2009; <b>115</b>(11): 2523–30. <a target=xrefwindow id=d38622e1487 href="http://www.ncbi.nlm.nih.gov/pubmed/19382202">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1490 href="http://dx.doi.org/10.1002/cncr.24284">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d38622e1499 class=n-a></a>Xiong MY, Rizzo AE, Cohen TS, <i> et al.</i>: Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial. <i>J Invest Dermatol.</i> 2013; <b>133</b>(6): 1521–32. <a target=xrefwindow id=d38622e1510 href="http://www.ncbi.nlm.nih.gov/pubmed/23348836">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1513 href="http://dx.doi.org/10.1038/jid.2013.35">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d38622e1523 class=n-a></a>Wang NJ, Sanborn Z, Arnett KL, <i> et al.</i>: Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(43): 17761–6. <a target=xrefwindow id=d38622e1534 href="http://www.ncbi.nlm.nih.gov/pubmed/22006338">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1537 href="http://dx.doi.org/10.1073/pnas.1114669108">Publisher Full Text </a> | <a target=xrefwindow id=d38622e1541 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3203814">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d38622e1550 class=n-a></a>Pickering CR, Zhou JH, Lee JJ, <i> et al.</i>: Mutational landscape of aggressive cutaneous squamous cell carcinoma. <i>Clin Cancer Res.</i> 2014; <b>20</b>(24): 6582–92. <a target=xrefwindow id=d38622e1561 href="http://www.ncbi.nlm.nih.gov/pubmed/25303977">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1564 href="http://dx.doi.org/10.1158/1078-0432.CCR-14-1768">Publisher Full Text </a> | <a target=xrefwindow id=d38622e1568 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4367811">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d38622e1577 class=n-a></a>South AP, Purdie KJ, Watt SA, <i> et al.</i>: <i>NOTCH1</i> mutations occur early during cutaneous squamous cell carcinogenesis. <i>J Invest Dermatol.</i> 2014; <b>134</b>(10): 2630–8. <a target=xrefwindow id=d38622e1591 href="http://www.ncbi.nlm.nih.gov/pubmed/24662767">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1595 href="http://dx.doi.org/10.1038/jid.2014.154">Publisher Full Text </a> | <a target=xrefwindow id=d38622e1598 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4753672">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d38622e1607 class=n-a></a>Ziegler A, Jonason AS, Leffell DJ, <i> et al.</i>: Sunburn and p53 in the onset of skin cancer. <i>Nature.</i> 1994; <b>372</b>(6508): 773–6. <a target=xrefwindow id=d38622e1618 href="http://www.ncbi.nlm.nih.gov/pubmed/7997263">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1621 href="http://dx.doi.org/10.1038/372773a0">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d38622e1630 class=n-a></a>Ståhl PL, Stranneheim H, Asplund A, <i> et al.</i>: Sun-induced nonsynonymous p53 mutations are extensively accumulated and tolerated in normal appearing human skin. <i>J Invest Dermatol.</i> 2011; <b>131</b>(2): 504–8. <a target=xrefwindow id=d38622e1641 href="http://www.ncbi.nlm.nih.gov/pubmed/20944651">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1644 href="http://dx.doi.org/10.1038/jid.2010.302">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d38622e1653 class=n-a></a>Jonason AS, Kunala S, Price GJ, <i> et al.</i>: Frequent clones of p53-mutated keratinocytes in normal human skin. <i>Proc Natl Acad Sci U S A.</i> 1996; <b>93</b>(24): 14025–9. <a target=xrefwindow id=d38622e1664 href="http://www.ncbi.nlm.nih.gov/pubmed/8943054">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1667 href="http://dx.doi.org/10.1073/pnas.93.24.14025">Publisher Full Text </a> | <a target=xrefwindow id=d38622e1671 href="http://www.ncbi.nlm.nih.gov/pmc/articles/19488">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d38622e1681 class=n-a></a>Zhang W, Remenyik E, Zelterman D, <i> et al.</i>: Escaping the stem cell compartment: sustained UVB exposure allows <i>p53</i>-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. <i>Proc Natl Acad Sci U S A.</i> 2001; <b>98</b>(24): 13948–53. <a target=xrefwindow id=d38622e1695 href="http://www.ncbi.nlm.nih.gov/pubmed/11707578">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1699 href="http://dx.doi.org/10.1073/pnas.241353198">Publisher Full Text </a> | <a target=xrefwindow id=d38622e1702 href="http://www.ncbi.nlm.nih.gov/pmc/articles/61147">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725509016"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1711 class=n-a></a>Martincorena I, Roshan A, Gerstung M, <i> et al.</i>: Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. <i>Science.</i> 2015; <b>348</b>(6237): 880–6. <a target=xrefwindow id=d38622e1722 href="http://www.ncbi.nlm.nih.gov/pubmed/25999502">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1725 href="http://dx.doi.org/10.1126/science.aaa6806">Publisher Full Text </a> | <a target=xrefwindow id=d38622e1729 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4471149">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725509016">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d38622e1742 class=n-a></a>Thompson SC, Jolley D, Marks R: Reduction of solar keratoses by regular sunscreen use. <i>N Engl J Med.</i> 1993; <b>329</b>(16): 1147–51. <a target=xrefwindow id=d38622e1750 href="http://www.ncbi.nlm.nih.gov/pubmed/8377777">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1753 href="http://dx.doi.org/10.1056/NEJM199310143291602">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d38622e1762 class=n-a></a>Green A, Williams G, Neale R, <i> et al.</i>: Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. <i>Lancet.</i> 1999; <b>354</b>(9180): 723–9. <a target=xrefwindow id=d38622e1773 href="http://www.ncbi.nlm.nih.gov/pubmed/10475183">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1776 href="http://dx.doi.org/10.1016/S0140-6736(98)12168-2">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d38622e1785 class=n-a></a>van der Pols JC, Williams GM, Pandeya N, <i> et al.</i>: Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. <i>Cancer Epidemiol Biomarkers Prev.</i> 2006; <b>15</b>(12): 2546–8. <a target=xrefwindow id=d38622e1796 href="http://www.ncbi.nlm.nih.gov/pubmed/17132769">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1799 href="http://dx.doi.org/10.1158/1055-9965.EPI-06-0352">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1183970"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1808 class=n-a></a>Ulrich C, Jürgensen JS, Degen A, <i> et al.</i>: Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. <i>Br J Dermatol.</i> 2009; <b>161</b>(Suppl 3): 78–84. <a target=xrefwindow id=d38622e1819 href="http://www.ncbi.nlm.nih.gov/pubmed/19775361">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1822 href="http://dx.doi.org/10.1111/j.1365-2133.2009.09453.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1183970">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717969390"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1836 class=n-a></a>Gupta AK, Paquet M, Villanueva E, <i> et al.</i>: Interventions for actinic keratoses. <i>Cochrane Database Syst Rev.</i> 2012; <b>12</b>: CD004415. <a target=xrefwindow id=d38622e1847 href="http://www.ncbi.nlm.nih.gov/pubmed/23235610">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1850 href="http://dx.doi.org/10.1002/14651858.CD004415.pub2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717969390">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d38622e1863 class=n-a></a>Krawtchenko N, Roewert-Huber J, Ulrich M, <i> et al.</i>: A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. <i>Br J Dermatol.</i> 2007; <b>157</b>(Suppl 2): 34–40. <a target=xrefwindow id=d38622e1874 href="http://www.ncbi.nlm.nih.gov/pubmed/18067630">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1877 href="http://dx.doi.org/10.1111/j.1365-2133.2007.08271.x">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d38622e1886 class=n-a></a>Pomerantz H, Hogan D, Eilers D, <i> et al.</i>: Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial. <i>JAMA Dermatol.</i> 2015; <b>151</b>(9): 952–60. <a target=xrefwindow id=d38622e1897 href="http://www.ncbi.nlm.nih.gov/pubmed/25950503">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1900 href="http://dx.doi.org/10.1001/jamadermatol.2015.0502">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732398233"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1909 class=n-a></a>Weinstock MA, Thwin SS, Siegel JA, <i> et al.</i>: Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial. <i>JAMA Dermatol.</i> 2018; <b>154</b>(2): 167–74. <a target=xrefwindow id=d38622e1920 href="http://www.ncbi.nlm.nih.gov/pubmed/29299592">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1923 href="http://dx.doi.org/10.1001/jamadermatol.2017.3631">Publisher Full Text </a> | <a target=xrefwindow id=d38622e1927 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5839275">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732398233">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727004381"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1940 class=n-a></a>Cunningham TJ, Tabacchi M, Eliane JP, <i> et al.</i>: Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. <i>J Clin Invest.</i> 2017; <b>127</b>(1): 106–16. <a target=xrefwindow id=d38622e1951 href="http://www.ncbi.nlm.nih.gov/pubmed/27869649">PubMed Abstract </a> | <a target=xrefwindow id=d38622e1954 href="http://dx.doi.org/10.1172/JCI89820">Publisher Full Text </a> | <a target=xrefwindow id=d38622e1958 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5199703">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727004381">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d38622e1971 class=n-a></a>Fallen RS, Gooderham M: Ingenol mebutate: an introduction. <i>Skin Therapy Lett.</i> 2012; <b>17</b>(2): 1–3. <a target=xrefwindow id=d38622e1979 href="http://www.ncbi.nlm.nih.gov/pubmed/22358305">PubMed Abstract </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717949376"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e1989 class=n-a></a>Lebwohl M, Swanson N, Anderson LL, <i> et al.</i>: Ingenol mebutate gel for actinic keratosis. <i>N Engl J Med.</i> 2012; <b>366</b>(11): 1010–9. <a target=xrefwindow id=d38622e2000 href="http://www.ncbi.nlm.nih.gov/pubmed/22417254">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2003 href="http://dx.doi.org/10.1056/NEJMoa1111170">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717949376">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d38622e2016 class=n-a></a>Lebwohl M, Shumack S, Stein Gold L, <i> et al.</i>: Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. <i>JAMA Dermatol.</i> 2013; <b>149</b>(6): 666–70. <a target=xrefwindow id=d38622e2027 href="http://www.ncbi.nlm.nih.gov/pubmed/23553119">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2030 href="http://dx.doi.org/10.1001/jamadermatol.2013.2766">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d38622e2039 class=n-a></a>Cozzi SJ, Ogbourne SM, James C, <i> et al.</i>: Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches. <i>J Invest Dermatol.</i> 2012; <b>132</b>(4): 1263–71. <a target=xrefwindow id=d38622e2050 href="http://www.ncbi.nlm.nih.gov/pubmed/22189786">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2053 href="http://dx.doi.org/10.1038/jid.2011.418">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d38622e2062 class=n-a></a>Angell-Petersen E, Sørensen R, Warloe T, <i> et al.</i>: Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. <i>J Invest Dermatol.</i> 2006; <b>126</b>(2): 265–71. <a target=xrefwindow id=d38622e2073 href="http://www.ncbi.nlm.nih.gov/pubmed/16374471">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2076 href="http://dx.doi.org/10.1038/sj.jid.5700048">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d38622e2085 class=n-a></a>Patel G, Armstrong AW, Eisen DB: Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratoses: a systematic review and meta-analysis. <i>JAMA Dermatol.</i> 2014; <b>150</b>(12): 1281–8. <a target=xrefwindow id=d38622e2093 href="http://www.ncbi.nlm.nih.gov/pubmed/25162181">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2096 href="http://dx.doi.org/10.1001/jamadermatol.2014.1253">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d38622e2105 class=n-a></a>Bagazgoitia L, Cuevas Santos J, Juarranz A, <i> et al.</i>: Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers. <i>Br J Dermatol.</i> 2011; <b>165</b>(1): 144–51. <a target=xrefwindow id=d38622e2116 href="http://www.ncbi.nlm.nih.gov/pubmed/21615716">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2119 href="http://dx.doi.org/10.1111/j.1365-2133.2011.10270.x">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d38622e2129 class=n-a></a>Stender IM, Bech-Thomsen N, Poulsen T, <i> et al.</i>: Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. <i>Photochem Photobiol.</i> 1997; <b>66</b>(4): 493–6. <a target=xrefwindow id=d38622e2140 href="http://www.ncbi.nlm.nih.gov/pubmed/9337620">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2143 href="http://dx.doi.org/10.1111/j.1751-1097.1997.tb03178.x">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d38622e2152 class=n-a></a>Willey A, Mehta S, Lee PK: Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. <i>Dermatol Surg.</i> 2010; <b>36</b>(5): 652–8. <a target=xrefwindow id=d38622e2160 href="http://www.ncbi.nlm.nih.gov/pubmed/19889154">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2163 href="http://dx.doi.org/10.1111/j.1524-4725.2009.01384.x">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d38622e2172 class=n-a></a>de Graaf YG, Kennedy C, Wolterbeek R, <i> et al.</i>: Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. <i>J Invest Dermatol.</i> 2006; <b>126</b>(3): 569–74. <a target=xrefwindow id=d38622e2183 href="http://www.ncbi.nlm.nih.gov/pubmed/16374480">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2186 href="http://dx.doi.org/10.1038/sj.jid.5700098">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d38622e2195 class=n-a></a>Togsverd-Bo K, Omland SH, Wulf HC, <i> et al.</i>: Primary prevention of skin dysplasia in renal transplant recipients with photodynamic therapy: a randomized controlled trial. <i>Am J Transplant.</i> 2015; <b>15</b>(11): 2986–90. <a target=xrefwindow id=d38622e2206 href="http://www.ncbi.nlm.nih.gov/pubmed/26018207">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2209 href="http://dx.doi.org/10.1111/ajt.13358">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d38622e2218 class=n-a></a>Rubel DM, Spelman L, Murrell DF, <i> et al.</i>: Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. <i>Br J Dermatol.</i> 2014; <b>171</b>(5): 1164–71. <a target=xrefwindow id=d38622e2229 href="http://www.ncbi.nlm.nih.gov/pubmed/24861492">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2232 href="http://dx.doi.org/10.1111/bjd.13138">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d38622e2241 class=n-a></a>Zito G, Saotome I, Liu Z, <i> et al.</i>: Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk. <i>Nat Commun.</i> 2014; <b>5</b>: 3543. <a target=xrefwindow id=d38622e2252 href="http://www.ncbi.nlm.nih.gov/pubmed/24667544">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2255 href="http://dx.doi.org/10.1038/ncomms4543">Publisher Full Text </a> | <a target=xrefwindow id=d38622e2259 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3974217">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d38622e2269 class=n-a></a>Bavinck JN, Tieben LM, Van der Woude FJ, <i> et al.</i>: Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. <i>J Clin Oncol.</i> 1995; <b>13</b>(8): 1933–8. <a target=xrefwindow id=d38622e2280 href="http://www.ncbi.nlm.nih.gov/pubmed/7636533">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2283 href="http://dx.doi.org/10.1200/JCO.1995.13.8.1933">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d38622e2292 class=n-a></a>Bettoli V, Zauli S, Virgili A: Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how. <i>J Dermatolog Treat.</i> 2013; <b>24</b>(3): 235–7. <a target=xrefwindow id=d38622e2300 href="http://www.ncbi.nlm.nih.gov/pubmed/23148804">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2303 href="http://dx.doi.org/10.3109/09546634.2012.746634">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d38622e2312 class=n-a></a>Kadakia KC, Barton DL, Loprinzi CL, <i> et al.</i>: Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251). <i>Cancer.</i> 2012; <b>118</b>(8): 2128–37. <a target=xrefwindow id=d38622e2323 href="http://www.ncbi.nlm.nih.gov/pubmed/21882176">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2326 href="http://dx.doi.org/10.1002/cncr.26374">Publisher Full Text </a> | <a target=xrefwindow id=d38622e2330 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3365547">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727428542"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e2339 class=n-a></a>Li J, Bonkowski MS, Moniot S, <i> et al.</i>: A conserved NAD<sup>+</sup> binding pocket that regulates protein-protein interactions during aging. <i>Science.</i> 2017; <b>355</b>(6331): 1312–7. <a target=xrefwindow id=d38622e2353 href="http://www.ncbi.nlm.nih.gov/pubmed/28336669">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2357 href="http://dx.doi.org/10.1126/science.aad8242">Publisher Full Text </a> | <a target=xrefwindow id=d38622e2360 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5456119">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727428542">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725865915"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e2373 class=n-a></a>Chen AC, Martin AJ, Choy B, <i> et al.</i>: A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. <i>N Engl J Med.</i> 2015; <b>373</b>(17): 1618–26. <a target=xrefwindow id=d38622e2384 href="http://www.ncbi.nlm.nih.gov/pubmed/26488693">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2387 href="http://dx.doi.org/10.1056/NEJMoa1506197">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725865915">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d38622e2400 class=n-a></a>Endrizzi B, Ahmed RL, Ray T, <i> et al.</i>: Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients. <i>Dermatol Surg.</i> 2013; <b>39</b>(4): 634–45. <a target=xrefwindow id=d38622e2411 href="http://www.ncbi.nlm.nih.gov/pubmed/23379978">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2414 href="http://dx.doi.org/10.1111/dsu.12049">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1164843"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e2424 class=n-a></a>Weinstock MA, Lee KC, Chren MM, <i> et al.</i>: Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial. <i>J Am Acad Dermatol.</i> 2009; <b>61</b>(2): 207–15. <a target=xrefwindow id=d38622e2435 href="http://www.ncbi.nlm.nih.gov/pubmed/19398145">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2438 href="http://dx.doi.org/10.1016/j.jaad.2009.02.022">Publisher Full Text </a> | <a target=xrefwindow id=d38622e2442 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3614359">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1164843">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d38622e2455 class=n-a></a>Hashim PW, Nia JK, Singer S, <i> et al.</i>: An Investigator-initiated Study to Assess the Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryosurgery in the Treatment of Hypertrophic Actinic Keratosis on Dorsal Hands. <i>J Clin Aesthet Dermatol.</i> 2016; <b>9</b>(7): 16–22. <a target=xrefwindow id=d38622e2466 href="http://www.ncbi.nlm.nih.gov/pubmed/27672408">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2469 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5022999">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726065699"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d38622e2478 class=n-a></a>Jambusaria-Pahlajani A, Ortman S, Schmults CD, <i> et al.</i>: Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients. <i>Dermatol Surg.</i> 2016; <b>42 Suppl 1</b>: S66–72. <a target=xrefwindow id=d38622e2489 href="http://www.ncbi.nlm.nih.gov/pubmed/26730976">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2492 href="http://dx.doi.org/10.1097/DSS.0000000000000589">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726065699">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d38622e2505 class=n-a></a>Berg D, Otley CC: Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. <i>J Am Acad Dermatol.</i> 2002; <b>47</b>(1): 1–17; quiz 18–20. <a target=xrefwindow id=d38622e2513 href="http://www.ncbi.nlm.nih.gov/pubmed/12077575">PubMed Abstract </a> | <a target=xrefwindow id=d38622e2516 href="http://dx.doi.org/10.1067/mjd.2002.125579">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 01 Jun 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-690.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-690.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Section of Dermatologic Surgery and Cutaneous Oncology, Department of Dermatology, Yale University, New Haven, CT, USA<br/> <p> <div class=margin-bottom> Sean R. Christensen <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-690/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 01 Jun 2018, 7:690 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12837.1">https://doi.org/10.12688/f1000research.12837.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Christensen SR. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13910 data-id=12837 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12837.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-690/v1/pdf?article_uuid=ffa282c2-0b8e-43d9-88c7-0dc7efd2f29e" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12837.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Christensen SR. Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):690 (<a href="https://doi.org/10.12688/f1000research.12837.1" target=_blank>https://doi.org/10.12688/f1000research.12837.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12837 id=mobile-track-article-signin-12837 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12837?target=/articles/7-690.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13910 /> <input name=articleId type=hidden value=12837 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>John Carucci</strong>, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center and School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Diona Damian</strong>, Department of Dermatology, University of Sydney, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 01 Jun 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-690.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-690.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=11834-34407></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=34845-34408></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-690/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>01 Jun 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>John Carucci</strong>, Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center and School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Diona Damian</strong>, Department of Dermatology, University of Sydney, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-690.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-690/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in field cancerization and...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-690/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-690/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-690/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Christensen SR');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-690/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-690",
            templates : {
                twitter : "Recent advances in field cancerization and management of multiple.... Christensen SR, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-690/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12837/13910")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13910");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "34407": 0,
                           "34408": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "b0c25acb-3206-4708-b64e-603acae84752";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-690.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-690.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-690.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-690.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-690.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>